TH17 cells in human recurrent pregnancy loss and pre-eclampsia

Cellular and Molecular Immunology

Volumn 11, Issue 6, 2014, Pages 564-570

  Fu, Binqing ^a,b   Tian, Zhigang ^a,b   Wei, Haiming ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

human pregnancy; pre eclampsia; recurrent spontaneous abortion; TH17 cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6;

CELL CYCLE REGULATION; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOTHER FETUS RELATIONSHIP; NONHUMAN; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY LOSS; PREGNANCY OUTCOME; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUS ABORTION; TH1 TH2 BALANCE; TH17 CELL; CELL DIFFERENTIATION; FEMALE; IMMUNOLOGY; IMMUNOMODULATION; PREGNANCY; RECURRENT ABORTION; UTERUS;

ABORTION, HABITUAL; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOMODULATION; PRE-ECLAMPSIA; PREGNANCY; TH17 CELLS; UTERUS;

EID: 84908499138     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.54     Document Type: Review

References (94)

1. Dong C. T-H 17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348
2. Ouyang WJ, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467
3. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517
4. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007; 51: 1139-1147
5. Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010; 21: 443-448
6. Saito S, Nakashima A, Ito M, Shima T. Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Expert Rev Clin Immunol 2011; 7: 649-657
7. Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010; 21: 443-448
8. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-171 T helper cells. Cell 2006; 126: 1121-1133
9. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10: 479-489
10. Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014; 20: 54-61
11. Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 2013; 190: 521-525
12. Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 2012; 67: 311-318
13. Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou GX et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol 2011; 65: 503-511
14. Wang WJ, Hao CF, Lin Y, Yin GJ, Bao SH, Qiu LH et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010; 84: 164-170
15. Toldi G, Rigo J, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in preeclampsia. Am J Reprod Immunol 2011; 66: 223-229
16. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol 2010; 88: 615-617
17. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy.AmJ Reprod Immunol 2010; 63: 601-610
18. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in thematernal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356
19. Vince GS, Johnson PM. Is there a Th2 bias in human pregnancy? J Reprod Immunol 1996; 32: 101-104
20. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/ Th3 paradigm. Semin Immunol 2001; 13: 219-227
21. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17: 7-17
22. Zhang JH, Chen ZL, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: maternal care before birth? Cell Mol Immunol 2011; 8: 1-11
23. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192: 259-270
24. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006; 27: 399-404
25. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol 2010; 63: 104-109
26. Ito M, Nakashima A, Hidaka T, Okabe M, Bac ND, Ina S et al. A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour. J Reprod Immunol 2010; 84: 75-85
27. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B et al. Systemic increase in the ratio between Foxp31 and IL-17-producing CD41 T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183: 7023-7030
28. Ostojic S, Dubanchet S, Chaouat G, Abdelkarim M, Truyens C, Capron F. Demonstration of the presence of IL-16 IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol 2003; 49: 101-112
29. Pongcharoen S, Niumsup P, Sanguansermsri D, Supalap K, Butkhamchot P. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 2006; 55: 291-300
30. Pongcharoen S, Supalap K. Interleukin-17 increased progesterone secretion by JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 2009; 61: 261-264
31. Martinez-Garcia EA, Chávez-Robles B, Sánchez-Hernández PE, Núñ ez-Atahualpa L, Martín-Máquez BT, Muñ oz-Gómez A et al. IL- 17 increased in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011; 65: 99-103
32. Heidt S, Segundo DS, Chadha R, Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transpl 2010; 15: 456-461
33. Hanidziar D, Koulmanda M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transpl 2010; 15: 411-415
34. Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6: 724-735
35. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD41CD251 regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10: 347-353
36. Yang H, Qiu L, Chen G, Ye Z, LüC, Lin Q. Proportional change of CD41CD251 regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril 2008; 89: 656-661
37. Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA, Offner H. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 2009; 126: 329-335
38. Ochanuna Z, Geiger-Maor A, Dembinsky-Vaknin A, Karussis D, Tykocinski ML, Rachmilewitz J. Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14. PLoS ONE 2010; 5: e12868.
39. Redman CW, Jefferies M. Revised definition of pre-eclampsia. Lancet 1988; 1: 809-812
40. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594
41. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leuk Biol 2013; 94: 247-257
42. Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA, Graham CH. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 2014; 211: 165-179
43. Zhou JJ, Hu YL, Wang ZQ, Zheng MM, Zhao X. Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am J Reprod Immunol 2010; 63: 38-45
44. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005
45. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59: 161-173
46. Saito S Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 550-555
47. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, OukkaMet al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238
48. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO et al. Transforming growth factor-beta induces development of the TH17 lineage. Nature 2006; 441: 231-234
49. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006; 203: 1685-1691
50. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189
51. Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010; 33: 279-288
52. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009; 10: 314-324
53. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496: 513-517
54. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D,Watowich SS et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282: 9358-9363
55. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008; 28: 29-39
56. Brustle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P et al. The development of inflammatory T-H-17 cells requires interferonregulatory factor 4. Nat Immunol 2007; 8: 958-966
57. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65-71
58. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106-109
59. Sacks GP, Studena K, Sargent IL, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80-86
60. Smarason AK, Gunnarsson A, Alfredsson JH, Valdimarsson H. Monocytosis and monocytic infiltration of decidua in early-pregnancy. J Clin Lab Immunol 1986; 21: 1-5
61. Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131: 490-497
62. Koumandakis E, Koumandaki I, Kaklamani E, Sparos L, Aravantinos D, Trichopoulos D. Enhanced phagocytosis of mononuclear phagocytes in pregnancy. Br J Obstet Gynaecol 1986; 93: 1150-1154
63. Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normalpregnancy. Eur J Obstetr Gynecol Reprod Biol 1994; 57: 149-155
64. Melczer Z, Bánhidy F, Csömör S, Tóth P, Kovács M, Winkler G et al. Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropometric parameters of newborns. Acta Obstet Gyn Scan 2003; 82: 432-438
65. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004; 19: 1025-1030
66. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 1998; 105: 632-640
67. Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005; 26: 515-526
68. Gupta AK, Rusterholz C, Huppertz B, Malek A, Schneider H, Holzgreve W et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 2005; 26: 59-66
69. Collins MK, Tay CS, Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/ fetal interface in mice. J Clin Invest 2009; 119: 2062-2073
70. Fu BQ, Li X, Sun R, Tong X, Ling B, Tian Z et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface Proc Natl Acad Sci USA 2013; 110: E231-E240
71. Wu W, Shi S, Ljunggren HG, Cava AL, Van Kaer L, Shi FD et al. NK cells inhibit T-bet-deficient, autoreactive Th17 cells. Scand J Immunol 2012; 76: 559-566
72. Hao JW, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 2010; 207: 1907-1921
73. Xu W, Fazekas G, Hara H, Tabira T. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J Neuroimmunol 2005; 163: 24-30
74. Zhang BN, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186: 1677-1687
75. Fu BQ, Wang F, Sun R, Ling B, Tian Z, Wei H. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011; 133: 350-359
76. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface Nat Med 2006; 12: 1065-1074
77. Yu X, Rollins D, Ruhn KA, Stubblefield JJ, Green CB, Kashiwada M et al. TH17 cell differentiation is regulated by the circadian clock. Science 2013; 342: 727-730
78. Curtis AM, Bellet MM, Sassone-Corsi P, O'Neill LA. Circadian clock proteins and immunity. Immunity 2014; 40: 178-186
79. Seillet C, Huntington ND, Gangatirkar P, Axelsson E, Minnich M, Brady HJ et al. Differential requirement for Nfil3 during NK cell development. J Immunol 2014; 192: 2667-2675
80. Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH, Lin QD The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod 2010; 25: 2591-2596
81. Stewart CA, Metheny H, Iida N, Smith L, Hanson M, Steinhagen F et al. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. J Clin Invest 2013; 123: 4859-4874
82. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463: 808-8120
83. Huber S, Gagliani N, Esplugues E, O'ConnorWJr, Huber FJ, Chaudhry A et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp32 and Foxp31 regulatory CD41 T cells in an interleukin-10- dependent manner. Immunity 2011; 34: 554-565
84. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17- producing cells. Blood 2008; 112: 2340-2352
85. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 2009; 183: 2475-2483
86. Vacca P, Cantoni C, Vitale M, Prato C, Canegallo F, Fenoglio D et al. Crosstalk between decidual NK and CD141 myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci USA 2010; 107: 11918-11923
87. Honig A, Rieger L, Kapp M, Sütterlin M, Dietl J, Kämmerer U. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. J Reprod Immunol 2014; 61: 79-86
88. Cooney LA, Towery K, Endres J, Fox DA. Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol 2011; 187: 4440-4450
89. Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, Joyce- Shaikh B et al. IL-27 Blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 2009; 182: 5748-5756
90. Hirahara K, Ghoreschi K, Yang XP, Takahashi H, Laurence A, VahediG et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 2012; 36: 1017-1030
91. El-Behi M, Ciric B, Yu S, Zhang GX, Fitzgerald DC, Rostami A. Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 2009; 183: 4957-4967
92. Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA et al. Pro-inflammatory human Th17 cells selectively express Pglycoprotein and are refractory to glucocorticoids. J Exp Med 2014; 211: 89-104
93. Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012; 13: 991-999
94. Fu BQ, Tian ZG, Wei HM. Subsets of human natural killer cells and their regulatory effects. Immunology 2014; 141: 483-489